liSENidPioneering the Future of EARLY CANCER DIAGNOSIS A New Standard in Cancer Diagnostics Every year, hundreds of thousands of tumor biopsies return ambiguous results — leaving patients and clinicians in limbo and resulting in repeated and follow-on tests, delayed treatment, and rising costs. At LisenID, we are eliminating this diagnostic gap with the first test […]